Michael Levy, MD, PhD - Publications

Affiliations: 
Neurology Johns Hopkins University, Baltimore, MD 
Area:
Neuromyelitis Optica

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Hollinger KR, Franke C, Arenivas A, Woods SR, Mealy MA, Levy M, Kaplin AI. Cognition, mood, and purpose in life in neuromyelitis optica spectrum disorder. Journal of the Neurological Sciences. 362: 85-90. PMID 26944124 DOI: 10.1016/j.jns.2016.01.010  0.44
2015 Mealy MA, Shin K, John G, Levy M. Bevacizumab is safe in acute relapses of neuromyelitis optica. Clinical & Experimental Neuroimmunology. 6: 413-418. PMID 26834844 DOI: 10.1111/cen3.12239  0.44
2015 Pekcevik Y, Orman G, Lee IH, Mealy MA, Levy M, Izbudak I. What do we know about brain contrast enhancement patterns in neuromyelitis optica? Clinical Imaging. PMID 26615899 DOI: 10.1016/j.clinimag.2015.07.027  0.44
2015 Levy M. The ethics of placebo controlled clinical trials in NMO - A balance of risks. Multiple Sclerosis and Related Disorders. 4: 512-4. PMID 26590656 DOI: 10.1016/j.msard.2015.07.016  0.44
2015 Juryńczyk M, Weinshenker B, Akman-Demir G, Asgari N, Barnes D, Boggild M, Chaudhuri A, D'hooghe M, Evangelou N, Geraldes R, Illes Z, Jacob A, Kim HJ, Kleiter I, Levy M, et al. Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes. Journal of Neurology. PMID 26530512 DOI: 10.1007/s00415-015-7952-8  0.44
2015 Mealy MA, Levy M. Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab. Journal of Neuroimmunology. 287: 29-30. PMID 26439958 DOI: 10.1016/j.jneuroim.2015.08.003  0.44
2015 Levy M, Boulis N, Rao M, Svendsen CN. Regenerative cellular therapies for neurologic diseases. Brain Research. PMID 26239912 DOI: 10.1016/j.brainres.2015.06.053  0.44
2015 Pekcevik Y, Mitchell CH, Mealy MA, Orman G, Lee IH, Newsome SD, Thompson CB, Pardo CA, Calabresi PA, Levy M, Izbudak I. Differentiating neuromyelitis optica from other causes of longitudinally extensive transverse myelitis on spinal magnetic resonance imaging. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 26209588 DOI: 10.1177/1352458515591069  0.44
2015 Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 85: 177-89. PMID 26092914 DOI: 10.1212/WNL.0000000000001729  0.44
2015 Raykova K, Jones MV, Huang H, Hoffman PF, Levy M. Minimally-invasive Technique for Injection into Rat Optic Nerve. Journal of Visualized Experiments : Jove. PMID 26068024 DOI: 10.3791/52249  0.44
2015 Mealy MA, Whetstone A, Orman G, Izbudak I, Calabresi PA, Levy M. Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis. Journal of the Neurological Sciences. PMID 26026942 DOI: 10.1016/j.jns.2015.05.013  0.44
2015 Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, et al. Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder. Jama Neurology. 72: 815-22. PMID 26010909 DOI: 10.1001/jamaneurol.2015.0248  0.44
2015 Abboud H, Petrak A, Mealy M, Sasidharan S, Siddique L, Levy M. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange. Multiple Sclerosis (Houndmills, Basingstoke, England). PMID 25921047 DOI: 10.1177/1352458515581438  0.44
2015 Weinshenker BG, Barron G, Behne JM, Bennett JL, Chin PS, Cree BA, de Seze J, Flor A, Fujihara K, Greenberg B, Higashi S, Holt W, Khan O, Knappertz V, Levy M, et al. Challenges and opportunities in designing clinical trials for neuromyelitis optica. Neurology. 84: 1805-15. PMID 25841026 DOI: 10.1212/WNL.0000000000001520  0.44
2013 Saini H, Rifkin R, Gorelik M, Huang H, Ferguson Z, Jones MV, Levy M. Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis. Bmc Neurology. 13: 104. PMID 23927715 DOI: 10.1186/1471-2377-13-104  0.44
2010 Saini H, Fernandez G, Kerr D, Levy M. Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity. Journal of Neuroimmunology. 221: 68-72. PMID 20227773 DOI: 10.1016/j.jneuroim.2010.02.007  0.44
2003 Levy M, Faas GC, Saggau P, Craigen WJ, Sweatt JD. Mitochondrial regulation of synaptic plasticity in the hippocampus. The Journal of Biological Chemistry. 278: 17727-34. PMID 12604600 DOI: 10.1074/jbc.M212878200  0.44
2002 Weeber EJ, Levy M, Sampson MJ, Anflous K, Armstrong DL, Brown SE, Sweatt JD, Craigen WJ. The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity. The Journal of Biological Chemistry. 277: 18891-7. PMID 11907043 DOI: 10.1074/jbc.M201649200  0.44
2002 Schrader LA, Anderson AE, Varga AW, Levy M, Sweatt JD. The other half of Hebb: K+ channels and the regulation of neuronal excitability in the hippocampus. Molecular Neurobiology. 25: 51-66. PMID 11890457 DOI: 10.1385/MN:25:1:051  0.44
Show low-probability matches.